SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-013889
Filing Date
2022-05-16
Accepted
2022-05-16 16:37:53
Documents
77
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 771583
2 ex31-1.htm EX-31.1 17250
3 ex31-2.htm EX-31.2 16929
4 ex32-1.htm EX-32.1 6767
5 ex32-2.htm EX-32.2 6740
  Complete submission text file 0001493152-22-013889.txt   4781756

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vvos-20220331.xsd EX-101.SCH 41336
7 XBRL CALCULATION FILE vvos-20220331_cal.xml EX-101.CAL 62797
8 XBRL DEFINITION FILE vvos-20220331_def.xml EX-101.DEF 146967
9 XBRL LABEL FILE vvos-20220331_lab.xml EX-101.LAB 333473
10 XBRL PRESENTATION FILE vvos-20220331_pre.xml EX-101.PRE 265671
71 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 682343
Mailing Address 9137 RIDGELINE BOULEVARD SUITE 135 HIGHLANDS RANCH CO 80129
Business Address 9137 RIDGELINE BOULEVARD SUITE 135 HIGHLANDS RANCH CO 80129 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

IRS No.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39796 | Film No.: 22930051
SIC: 3841 Surgical & Medical Instruments & Apparatus